
The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III
Keywords: HCC; EGFR; epidermal growth factor receptor; EGFRvIII; epidermal growth factor receptor variant III; HCC; hepatocellular carcinoma; 5-FU; 5-fluorouracil; DPYD; dihydrouracil dehydrogenase; OPRT; orotate phosphoribosyltransferase; TS; thymidylate synthase; Epid